The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML-Reference-Cited by-同舟云学术

The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML

Published:2019-06-21 Issue:8 Volume:94 Page:913-920
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Dunlap Jennifer B.¹^ORCID,Leonard Jessica²³,Rosenberg Mara²,Cook Rachel²³,Press Richard¹²^ORCID,Fan Guang¹,Raess Philipp W.¹,Druker Brian J.²³⁴,Traer Elie²³^ORCID

Affiliation:

1. Department of PathologyOregon Health & Science University Portland Oregon

2. Knight Cancer InstituteOregon Health & Science University Portland Oregon

3. Division of Hematology and Medical OncologyOregon Health & Science University Portland Oregon

4. Howard Hughes Medical Institute Chevy Chase Maryland

Funder

Leukemia and Lymphoma Society

American Cancer Society

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25517

Reference28 articles.

1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

2. Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

3. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

4. Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse

5. Minimal residual disease in acute myeloid leukaemia

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of genetic co‐mutation on chemotherapeutic outcome in NPM1‐mutated and FLT3‐ITD wild‐type AML patients;Cancer Medicine;2024-08

2. Significance of targeting DNMT3A mutations in AML;Annals of Hematology;2024-07-30

3. Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes;Cancer Cell International;2024-05-19

4. Ring finger protein 138 inhibits transcription factor C/EBPα protein turnover leading to differentiation arrest in acute myeloid leukemia;Biochemical Journal;2024-05-10

5. Clinical prognostic value of different NPM1 mutations in acute myeloid leukemia patients;Annals of Hematology;2024-05-09